default author photo

Xiangcai Wang

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

53

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Efficacy and Safety of Envafolimab, Suvemcitug and Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer: An Open-Label Phase Ii Clinical Trial

Number of pages: 24 Posted: 10 Jan 2025
Ying Cheng, Chunjiao Wu, Lin Wu, Xiangjiao Meng, Yan Wang, Qingxia Fan, Xiangcai Wang, Kangsheng Gu, Rui Ma, Changlu Hu, Liqin Lu, Fang Su, Chen Yang, Zhenru Liu, Ji Tian, Xiyang Sun and Shuguang Sun
Jilin Cancer Hospital - Department of Oncology, Jilin Cancer Hospital, Zhengzhou University - Henan Provincial People's Hospital, Shandong Provincial Cancer Hospital, affiliation not provided to SSRN, The First Affiliated Hospital of Zhengzhou University, affiliation not provided to SSRN, Anhui Medical University, affiliation not provided to SSRN, Anhui Provincial Cancer Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 53 (1,041,696)

Abstract:

Loading...

Non-small cell lung cancer, Suvemcitug, Anti-angiogenesis, Envafolimab, immune checkpoint inhibitor